PODCAST · science
GO StudiO
by Laura Venegas
“Where gynecologic oncology thinks out loud”
Episodes
-
Salpingectomy for the Prevention of Epithelial Ovarian Cancer: Clinical Practice Update
The October 2026 Clinical Practice Update from the American College of Obstetricians & Gynecologists (ACOG) reinforces and expands the role of bilateral salpingectomy as a primary prevention strategy for epithelial ovarian cancer. Grounded in evolving pathologic evidence that identifies the...
-
Is there an association between hyperandrogenic states in women and endrometrial cancer?
Many women suffer from hyperandrogenic conditions during their lifespan. The most prevalent is polycystic ovary syndrome (PCOS), which is characterized by hormonal, metabolic, and reproductive derangements in women of reproductive age. Endometrial cancer of epithelial origin (EC) is among the…
more -
Rethinking ovarian cancer IIIRethinking ovarian cancer III
The provided text outlines a comprehensive expert recommendation and roadmap for the future of high-grade serous carcinoma (HGSC) research and treatment. Drawing from the 15th Helene Harris Memorial Trust International Forum, the document synthesizes a decade of progress while identifying…
more -
The Invisible Gorilla: Impact of Immediate Surgical Second Looks
This study investigates the prevalence of undetected malignant nodules during surgery for colorectal and ovarian cancer that has spread to the peritoneum. Researchers conducted a prospective trial where a second senior surgeon performed an immediate re-evaluation of the abdomen after the primary...
-
ESMOTAT2026
Drugging the undruggable through novel synthetic lethal strategies This session highlights how leveraging synthetic lethality is opening new therapeutic avenues for targets once considered beyond reach. A promising step forward in precision oncology and the development of more effective,...
-
Optimal bevacizumab treatment strategy in advanced ovarian cancer
The addition of bevacizumab to chemotherapy has been shown to improve progression-free survival (PFS) in patients with ovarian cancer, with the greatest benefit observed in those with high-risk disease, and the combination of bevacizumab and olaparib has been approved as a first-line maintenance...
-
Innovation in Ovarian Cancer: The Role of Antibody–Drug Conjugates (ADCs)
This episode explores the growing role of antibody–drug conjugates (ADCs) in the treatment of ovarian cancer. ADCs combine a targeted monoclonal antibody with a cytotoxic drug, allowing chemotherapy to be delivered directly to tumor cells while limiting damage to healthy tissue. The discussion...
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
Loading similar podcasts...
Frequently Asked Questions
How many episodes does GO StudiO have?
GO StudiO currently has 7 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is GO StudiO about?
“Where gynecologic oncology thinks out loud”
How often does GO StudiO release new episodes?
GO StudiO has 7 episodes. Check the episode list to see recent publication dates and frequency.
Where can I listen to GO StudiO?
You can listen to GO StudiO on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts GO StudiO?
GO StudiO is created and hosted by Laura Venegas.
URL copied to clipboard!